Medroxyprogesterone acetate (MPA)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Medroxyprogesterone acetate (MPA), covering 2023-02-17 to 2023-02-17. Get the full timeline:
Most recent: Clinical Trial Update: MPA Versus Dydrogesterone for Management of Endometrial Hyperplasia Without Atypia [Phase 3]